TXMD Press Releases

TherapeuticsMD announces oral presentation of positive phase 2 and bioavailability data on TX-004HR (VagiCapTM)
15 October 2014

TherapeuticsMD Inc. granted two new patents
30 September 2014

TherapeuticsMD begins phase 3 clinical trial of TX-004HR
29 September 2014

Click here for all press releases